Effect and Complication of Two Types of Nasogastric Tube Feeding for Elderly Dysphagia Patient After Stroke

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03844139
Collaborator
(none)
100
1
22.6
4.4

Study Details

Study Description

Brief Summary

Dysphagia is a common problem after stroke.Patients after stroke with swallow problem will have a nasogastric tube to be feeded. In this study , investigators have including and excluding criteria. Continous feeding group and intermittent feeding group had been widely used in enteral nutrition feeding in investigators' institution. Investigators will observe participants' nutrition condition and tube-feeding related complications. In continous group patients, participants usually are given prescribed enteral nutrient solution using nutrition pump in 24 hours; while in intermittent feeding group, participants will be given prescribed enteral nutrient solution in 4-5 times by special syringe. During the whole process, investigators will observe all participants' nutrition condition (body mass index, plasma albumin and calf girth) and tube-feeding related complications( regurgitation, aspiration,gastric retention, diarrhea,constipation). With all those data, the investigators will assess which feeding type is better.

Condition or Disease Intervention/Treatment Phase
  • Device: Feeding pump and glycerin syringe

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Observation of Effect and Complication of Two Types of Nasogastric Tube Feeding Enteral Nutrition for Elderly Dysphagia Patients After Stroke
Actual Study Start Date :
Feb 13, 2019
Anticipated Primary Completion Date :
Jun 30, 2020
Anticipated Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Feeding pump group(continous)

Using the feeding pump to give patients prescribed enteral nutrient solution through nasogastric tube in 24 hours

Device: Feeding pump and glycerin syringe
The continuous group use feeding pump and the intermittent group use syringe to give dysphagia patients after stroke prescribed nutrition through nasogastric tube.

Glycerin syringe group(intermittent)

Using the glycerin syringe to give patients prescribed enteral nutrient solution through nasogastric tube in 4-5 times

Device: Feeding pump and glycerin syringe
The continuous group use feeding pump and the intermittent group use syringe to give dysphagia patients after stroke prescribed nutrition through nasogastric tube.

Outcome Measures

Primary Outcome Measures

  1. weight [4-6 weeks]

    weight in kilogram every week

  2. plasma albumin [4-6 weeks]

    plasma albumin every week

  3. tube-feeding related complications( regurgitation, aspiration,gastric retention, diarrhea,constipation) [4-6 weeks]

    incidence of each complication

Secondary Outcome Measures

  1. calf girth [4-6 weeks]

    length of calf girth

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Older than 65 years old

  • Clinical diagnosis of stroke( ischemic and hemorrhage)

  • With moderate and/or sever swallow problem(water swallow test IV-V degree)

  • With nasogastric feeding tube more than 4 weeks

  • Do rehabilitation in our hospital or designated hospitals

Exclusion Criteria:
  • Without nasogastric feeding tube

  • Patients with fever and other infection

  • Chronic or acute anoxia

  • Poor obedience

  • Quit treatment or go back home to take rehabilitation

  • Critically ill or died

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhangy Yuejiao Hangzhou Zhejiang China 310009

Sponsors and Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Second Affiliated Hospital, School of Medicine, Zhejiang University
ClinicalTrials.gov Identifier:
NCT03844139
Other Study ID Numbers:
  • zhang yuejiao
First Posted:
Feb 18, 2019
Last Update Posted:
Feb 13, 2020
Last Verified:
Feb 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 13, 2020